Unibest

Pharmaceutical intermediates

Calcipotriol Intermediates

3 pharmaceutical intermediates for Calcipotriol. Indication: Psoriasis; Plaque psoriasis.

Submit a ProjectAll intermediates

About Calcipotriol

Originator
Leo Pharmaceutical Products Ltd
Indication
Psoriasis; Plaque psoriasis
Approved Date
01/01/1990

Available intermediates

3 intermediates currently listed for Calcipotriol. Request specifications, documentation or a quotation for any item below.

Calcipotriol intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one112849-17-9//
Bis-TBDMS-trans-calcipotriol112849-27-1//
(5E)-Calcipotriene113082-99-8//

Other programs under C

Cabozantinib S-malateCalcitriolCamlipixantCanagliflozinCangrelor TetrasodiumCapivasertib Capmatinib HydrochlorideCarfilzomib

Building toward Calcipotriol?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →